In addition to genetic events, a variety of epigenetic events have been widely reported to contribute to file Onset of many diseases including cancer. DNA methylation and historic modifications (such as acetylation, methylation, sumoylation, and phosphorylation) involving chromatin remodelling are among the most studied epigenetic mechanisms for regulation of gene expression leading, when altered, to some diseases. Epigenetic therapy tries to reverse the aberrations followed to the disruption of the balance of the epigenetic signalling ways through the use of both natural compounds and synthetic molecules, active on Specific epi-targets. Such epi-drugs are, for example, inhibitors of DNA methyltransferases, histone deacetylases, histone acetyltransferases, histone methyltransferases, and histone demethylases. In this review we will focus Oil the chemical aspects Of such molecules joined to their effective (or potential) application in cancer therapy. (C) 2008 Elsevier Ltd. All rights reserved.

Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead / Mai, Antonello; Lucia, Altucci. - In: THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. - ISSN 1357-2725. - 41:1(2009), pp. 199-213. [10.1016/j.biocel.2008.08.020]

Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead

MAI, Antonello;
2009

Abstract

In addition to genetic events, a variety of epigenetic events have been widely reported to contribute to file Onset of many diseases including cancer. DNA methylation and historic modifications (such as acetylation, methylation, sumoylation, and phosphorylation) involving chromatin remodelling are among the most studied epigenetic mechanisms for regulation of gene expression leading, when altered, to some diseases. Epigenetic therapy tries to reverse the aberrations followed to the disruption of the balance of the epigenetic signalling ways through the use of both natural compounds and synthetic molecules, active on Specific epi-targets. Such epi-drugs are, for example, inhibitors of DNA methyltransferases, histone deacetylases, histone acetyltransferases, histone methyltransferases, and histone demethylases. In this review we will focus Oil the chemical aspects Of such molecules joined to their effective (or potential) application in cancer therapy. (C) 2008 Elsevier Ltd. All rights reserved.
2009
chromatin remodelling; dna methyltransferase; epigenetics; histone acetyltransferase; histone deacetylase; histone demethylase; histone methyltransferase
01 Pubblicazione su rivista::01a Articolo in rivista
Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead / Mai, Antonello; Lucia, Altucci. - In: THE INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. - ISSN 1357-2725. - 41:1(2009), pp. 199-213. [10.1016/j.biocel.2008.08.020]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/13146
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 49
  • Scopus 177
  • ???jsp.display-item.citation.isi??? 161
social impact